Kevin Michael Donahue, 10% Owner at MAINZ BIOMED N.V. (MYNZ), bought 685,000 shares at $1.51 ($1.0M) on 2025-10-17, disclosed to the SEC on 2026-01-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.